FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Amneal Pharmaceuticals Primidone Tablets Recall

Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal…

Amneal Pharmaceuticals, LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Jun 17, 2026
Recall ID
D-0585-2026
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled Primidone Tablets starting Jun 3, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0585-2026 on Jun 17, 2026. Reason: Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer. Status: Ongoing.

Why it was recalled

Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.

Product description

Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 53746-544-01

Lot numbers, UPCs & expiration codes

Lot AM251676, EXP 11/31/2028

Where it was sold

Nationwide within the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0585-2026
Classification
Class III
Status
Ongoing
Recall initiated
Jun 3, 2026
FDA report date
Jun 17, 2026
Quantity
27,936 100-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0585-2026, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
99146
Address
400 Crossing Blvd Fl 3
Code information
Lot AM251676, EXP 11/31/2028
Postal code
08807-2863
Report date
Jun 17, 2026
Product type
Drugs
Recall number
D-0585-2026
Classification
Class III
Recalling firm
Amneal Pharmaceuticals, LLC
Product quantity
27,936 100-count bottles
Reason for recall
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213, INDIA. Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC: 53746-544-01
Distribution pattern
Nationwide within the USA.
Recall initiation date
Jun 3, 2026
Initial firm notification
Letter
Center classification date
Jun 10, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0585-2026, published Jun 17, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls